2008
DOI: 10.1016/j.arcmed.2007.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Staging, Response to Therapy, and Restaging of Lymphomas with 18F-FDG PET

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 16 publications
0
1
0
1
Order By: Relevance
“…Being invasive, each has its own list of complications. 18 F-FDG PET-CT, a recently introduced noninvasive imaging modality, has been included in the staging of lymphoma and has been found to have higher sensitivity than CT.[13] However, FDG is not specific for detecting malignant conditions. It has been shown that inflammatory cells also show avidity for FDG.…”
Section: Discussionmentioning
confidence: 99%
“…Being invasive, each has its own list of complications. 18 F-FDG PET-CT, a recently introduced noninvasive imaging modality, has been included in the staging of lymphoma and has been found to have higher sensitivity than CT.[13] However, FDG is not specific for detecting malignant conditions. It has been shown that inflammatory cells also show avidity for FDG.…”
Section: Discussionmentioning
confidence: 99%
“…Allo stato attuale la PET/TC con FDG è la metodica più adeguata nella valutazione dell'estensione di malattia e nel follow-up in pazienti con linfoma e ha mostrato, inoltre, un'elevata accuratezza diagnostica nella ristadiazione dopo il trattamento iniziale. La PET con FDG permette altresì di predire in maniera precoce la risposta alla terapia e di valutare masse residue dopo chemioterapia o radioterapia [11,23,24].…”
Section: Linfomaunclassified